P-533: Metabolic syndrome in hypertensive patients with left ventricular hypertrophy

Metabolic syndrome (MS) carries of a number of risk factors for some patients with cardiovascular (CV) diseases. These risk factors, including isulin resistence, dyslipidermia, hypertension and obesity, increase the risk of the development of DM and multiply the risk of CV diseases. Aim: To prove the presence of MS in patients with hypertension and LVH analysing clinical parametres and to estimate the impact of this syndrome on patient prognosis. Methods: There have been analysed 73 hypertensive patients (43 male patients), avarage age 56.3 ± 8.5 with echo proved LVH (avarage LV mass index 163.5 ± 31,8 g/m2). Every patient has got the following results echo, ECG, treadmill exercise testing, 24-hour AMBP and 24-hour Holter monitoring (analysis of ventricular arrhythmias-VA and heart rate variablility - HRV). MS is defined according to NCEP ATP III. Results: 36 patients (55 ± 8 years) fulfilled the criterion of MS. They had significantly higher glucose level (5.9 ± 1 vs 5.1 ± 0.6. p